China Medical Board
An American foundation advancing health education, health systems, equity, and care quality in China and Southeast Asia.
Last updated August 26, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
China Medical Board (CMB) is an American philanthropic foundation focused on strengthening health professional education, medical research, health policy, health systems, and leadership in China and Southeast Asia. It began in 1914 as the second major project of the Rockefeller Foundation and was created during a period when philanthropic and educational institutions were seeking to introduce modern Western medical training into China. Its most prominent early institutional achievement was the development of Peking Union Medical College, which became one of China’s leading centers for medical education and biomedical research. From its inception, CMB’s stated institutional objective was not simply to operate a foreign medical school, but to help establish a high-quality Chinese institution that could eventually be owned, managed, staffed, and financed by Chinese professionals. That transition was substantially realized by 1950, when Peking Union Medical College had achieved an essentially Chinese faculty. CMB became an independent private foundation in 1928 after receiving additional endowment support from the Rockefeller Foundation. Political conditions prevented CMB from continuing normal operations in mainland China after 1951. During this period, the organization redirected much of its attention toward public-health and medical-education development elsewhere in East and Southeast Asia. Its regional work included support for medical schools, training facilities, laboratories, educational materials, fellowships, and faculty development. The organization’s historical reach eventually extended to medical schools in numerous Asian countries, including a substantial number of institutions in China. CMB was invited to resume work in China in 1980 and has maintained a continuing presence there since then. Its modern approach emphasizes institutional capacity building rather than direct clinical service or the sale of health products. The foundation works with medical universities and related partners to improve the preparation of health professionals, strengthen health-policy research, develop health-system leadership, and address disparities in access and outcomes. Current program areas include health professional education, health policy and systems, global health, and leadership development. CMB reports working with 24 medical universities in China and parts of Southeast Asia. In 2016, it launched The Equity Initiative, a long-term fellowship and leadership-development program intended to cultivate leaders working on health equity in Southeast Asia. Through grants, partnerships, fellowships, and institutional support, CMB operates as a cross-border philanthropic platform connecting universities, public-health researchers, policymakers, and health-system leaders. The foundation is not a listed company and does not market conventional consumer products. Its principal offerings are grants, fellowships, educational partnerships, research support, and leadership programs. Its contemporary positioning rests on long-term institutional development, regional collaboration, and the improvement of health equity and care quality. Roger I. Glass, MD, PhD, is identified in the supplied reference material as its current president.
History
China Medical Board was established in 1914 as the second major project of the Rockefeller Foundation. Its early work was shaped by the effort to create a modern medical education and research institution in China. The organization helped establish and develop Peking Union Medical College, which became a leading center for Western-style medical training, clinical practice, and biomedical research in the country. CMB’s original institutional philosophy emphasized eventual Chinese ownership and leadership. Rather than maintaining a permanently foreign-run institution, the project sought to train local physicians, scientists, teachers, and administrators capable of operating the medical college and contributing to the wider health system. By 1950, the college had achieved an essentially Chinese faculty, marking an important stage in that transition. In 1928, following additional endowment support from the Rockefeller Foundation, China Medical Board became an independent private foundation. Its work nevertheless remained closely associated with the broader history of Rockefeller philanthropy, medical modernization, and international public-health development in the first half of the twentieth century. Political circumstances halted CMB’s ability to operate normally in mainland China in 1951. The foundation responded by shifting attention toward other countries in East Asia and Southeast Asia. Its regional activities supported medical schools and public-health institutions through facilities, laboratories, educational materials, fellowships, and faculty-development assistance. Over time, the organization supported 118 medical schools in 17 Asian countries, including 28 in China, according to the supplied reference material. CMB returned to China in 1980 after receiving an invitation to resume its activities. Since that time, it has maintained a continuous presence in the country while also continuing regional work in Southeast Asia. Its focus has evolved from the creation of a flagship medical college toward broader capacity building across health professional education, health policy, health systems, global health, and leadership. The foundation’s contemporary model is partnership-based. It works with universities and other institutions rather than functioning as a conventional hospital operator, educational retailer, or pharmaceutical company. Its support can include grants, fellowships, research collaboration, institutional strengthening, curriculum and faculty development, and leadership training. The stated mission is to advance health, equity, and the quality of care in China and Southeast Asia. In 2016, CMB created The Equity Initiative, a long-term fellowship program intended to develop leaders addressing health inequities in Southeast Asia. The program reflects the foundation’s broader shift toward leadership and systems-level change, complementing its historical emphasis on medical education. CMB currently reports partnerships with 24 medical universities in China and parts of Southeast Asia, including Thailand, Vietnam, Laos, and Myanmar. Roger I. Glass, MD, PhD, is identified as the foundation’s current president in the supplied reference material.
- 2016
The Equity Initiative is launched
[1]CMB introduces a long-term fellowship and leadership-development program focused on health equity in Southeast Asia.
- 1980
CMB returns to China
[1]China Medical Board is invited to resume activities in China and subsequently maintains a continuing presence there.
- 1951
Operations in mainland China are interrupted
[1]Political conditions prevent CMB from continuing its normal activities in China, prompting a shift toward other Asian countries.
- 1950
Peking Union Medical College reaches a major localization milestone
[1]The medical college has achieved an essentially Chinese faculty, advancing CMB’s founding goal of Chinese institutional ownership and leadership.
- 1928
CMB becomes an independent private foundation
[1]After receiving further endowment support from the Rockefeller Foundation, China Medical Board becomes an independent private foundation.
- 1914
China Medical Board is founded
[1]China Medical Board begins as the second major project of the Rockefeller Foundation, with a mandate connected to medical education and health development in China.
Products and positioning
A long-term philanthropic partner for medical education, health-system improvement, health equity, and leadership development in China and Southeast Asia.
Medical education and research institution development · 1914
Peking Union Medical College support
CMB’s foundational institutional project was the development of Peking Union Medical College. The initiative brought modern Western medical education and research methods to China while aiming to create a self-sustaining institution led and staffed by Chinese professionals. The college became a prominent center for medical training and biomedical research and remains the defining legacy of CMB’s early work.
Fellowship and leadership development · 2016
The Equity Initiative
The Equity Initiative is a long-term fellowship program launched to nurture leaders working on health equity in Southeast Asia. It reflects CMB’s contemporary emphasis on leadership, cross-sector collaboration, and structural improvements in access, policy, and health-system performance rather than short-term service delivery alone.
Education and institutional capacity building
Health professional education partnerships
CMB supports medical universities and related institutions through grants, educational resources, faculty development, fellowships, laboratories, and other forms of institutional capacity building. These partnerships are intended to improve the quality and relevance of health-professional training in China and Southeast Asia.
Health policy and global health
Health policy and systems programs
CMB’s current portfolio includes support for health policy, health systems, and global health research and practice. The work connects academic institutions and health leaders with the goal of improving policy capacity, care quality, equity, and system performance.
Marketing campaigns
- 2016The Equity Initiative
Thailand · Vietnam · Laos · Myanmar · Other parts of Southeast Asia
A long-term fellowship and leadership-development effort focused on building a network of people working to improve health equity across Southeast Asia.
Outcome. The available reference material does not provide quantified outcomes, but identifies the initiative as an ongoing component of CMB’s regional leadership strategy.
Brand decisions
2016
Launching The Equity InitiativeProduct launchBackground
CMB broadened its focus toward health equity and leadership development in Southeast Asia.
Action taken
The foundation created a long-term fellowship program to cultivate health-equity leaders.
Aftermath
The initiative became a visible part of CMB’s contemporary regional strategy.
1980
Resuming activities in ChinaStrategyBackground
After nearly three decades away from mainland China, CMB received an invitation to resume its activities.
Action taken
The foundation re-established work in China while retaining its broader regional orientation.
Aftermath
CMB has maintained a continuous presence in China and now combines China-based partnerships with Southeast Asian programs.
1951
Redirecting regional work after the interruption in ChinaStrategyBackground
Political conditions prevented China Medical Board from operating normally in mainland China.
Action taken
CMB shifted its attention toward public-health and medical-education development in other East and Southeast Asian countries.
Aftermath
The foundation expanded its regional capacity-building role before returning to China in 1980.
Recent events
- 2016
China Medical Board launches The Equity Initiative[1]
Campaign · Product launch
The foundation introduced a long-term fellowship and leadership program designed to develop health-equity leaders in Southeast Asia.
- 1980
China Medical Board resumes activities in China[1]
Other
After being unable to operate in mainland China for political reasons from 1951, China Medical Board was invited to return and has continued working in China since then.
Sources3 sources
Cite this profile: Cite the canonical profile. /brand-wiki/china-medical-board · Editorial policy · How profiles are compiled